ALX Oncology Holdings Inc (NAS:ALXO)
$ 2.015 +0.035 (+1.77%) Market Cap: 275.17 Mil Enterprise Value: 146.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

ALX Oncology Holdings Inc Annual Shareholders Meeting Transcript

Jun 10, 2026 / 08:00PM GMT
Release Date Price: $1.46 (-5.81%)
Jason Lettmann
ALX Oncology Holdings Inc - Chief Executive Officer, Director

Good afternoon, ladies and gentlemen. I am Jason Lettmann, Chief Executive Officer of ALX Oncology Holdings, and as the Chairperson of this meeting, it is a pleasure to welcome you to ALX's Annual Meeting of Stockholders. I have asked Harish Shantharam, our Chief Financial Officer, to act as Secretary of this meeting and record the minutes. This year, we are again holding a virtual annual meeting of stockholders. We believe in engaging with our stockholders and maximizing their ability to meaningfully engage with us. We are pleased that our stockholders, no matter where they are located in the world today, can participate in the meeting in a virtual format.

Before proceeding further, let me introduce the other directors and Director Nominees of the company who are in attendance: Dr. Corey Goodman, Dr. Daniel Curran, Scott Garland, Rekha Hemrajani, Dr. Alan Sandler, Dr. Chris Takimoto.

I would also like to introduce the members of company management who are also in attendance: Dr. Barbara Klencke, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot